Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYNO

Cynosure (CYNO) Stock Price, News & Analysis

Cynosure logo

About Cynosure Stock (NASDAQ:CYNO)

Advanced Chart

Key Stats

Today's Range
$66.00
$66.00
50-Day Range
N/A
52-Week Range
$39.90
$66.65
Volume
N/A
Average Volume
1.24 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cynosure, Inc. develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women's health. The Company also markets radiofrequency (RF), energy-sourced medical devices for surgical applications, such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. The Company sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names. Its product portfolio includes single energy source systems, as well as workstations that incorporate two or more different types of lasers or light-based technologies.

Receive CYNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cynosure and its competitors with MarketBeat's FREE daily newsletter.

CYNO Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

CYNO Stock Analysis - Frequently Asked Questions

Cynosure, Inc. (NASDAQ:CYNO) posted its quarterly earnings data on Tuesday, July, 26th. The medical equipment provider reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.07. The business's quarterly revenue was up 31.8% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cynosure investors own include Global Blood Therapeutics (GBT), Hawkins (HWKN), DHT (DHT), NVIDIA (NVDA), Xtrackers California Municipal Bond ETF (CA), Golar LNG Partners (GMLP) and Micron Technology (MU).

Company Calendar

Last Earnings
7/26/2016
Today
5/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:CYNO
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:CYNO) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners